Analytical Data
-
Gene name
GALP
- Application
-
Alternative Names
GALP；Galanin-like peptide
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UBC7
-
Expression Region
25-84aa
-
AA Sequence
APAHRG RGGWTLNSAG YLLGPVLHLP QMGDQDGKRE TALEILDLWK AIDGLPYSHP PQPS
-
Molecular Weight
12.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GALP (Galanin-like peptide) is a neuropeptide that has gained attention in the field of biomedical research due to its involvement in several physiological processes, including appetite regulation, energy homeostasis, and stress responses. Originating from the hypothalamus, GALP interacts with galanin receptors, influencing neuroendocrine functions and potentially serving as a target for obesity and metabolic disorder treatments. Research on GALP is pivotal as it provides insights into its roles in neurobiology and metabolic regulation. The structural characteristics and conformational dynamics of GALP, as well as its interaction with receptors, are crucial for understanding its functional mechanisms. Recombinant GALP production allows scientists to study its properties in a controlled environment, enabling investigations into its pharmacological applications. Understanding the structure-function relationship of GALP can lead to the discovery of novel therapeutic approaches for obesity and related metabolic conditions. As research progresses, the potential of GALP as a biomarker or therapeutic target may unveil new pathways for treating metabolic disorders and improving health outcomes.
